About this episode
Flawless skin. Thicker hair. A snatched jawline. Better sleep. These are some of the benefits social media users claim peptides can deliver. But many of these uses are not FDA-approved, and consumers are increasingly turning to the grey market. WSJ’s Sara Ashley O’Brien, who covers the business and culture of wellness, joins host Alex Ossola to discuss the reality behind the hype and the risks involved.
Further Reading
The Explosive Rise of Unapproved Peptide Injections
Teen Boys and Young Men Are Injecting Peptides in Search of Perfection
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time WSJ What’s News publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from WSJ What’s News
Surging Bond Yields Pile Pressure on the Fed
WSJ What’s News
Trump Rejects Calls for AI Regulation Amid Industry Fears Over Safety
WSJ What’s News
Fearing a Loss of Control, AI Bosses Call for Tech Slowdown
WSJ What’s News
Inside Pete Hegseth’s Pentagon Shake-Up
WSJ What’s News